Summary
Interleukin-15 (IL-15) is a 4-helix bundle cytokine with similar biologic properties as IL-2, consistent with their shared receptor subunits. Specificity for IL-15 and IL-2 is provided by unique private a-chain subunits. Studies to date examining the biology of IL-15 have identified several roles for this cytokine in both the differentiation as well as function of immune cells. IL-15 is important for NK cell, NK-T-cell, CD8 T-cell, and intestinal epithelial lymphocyte (IEL) growth and function. Recently, overexpression of IL-15 in diseased tissue has provided evidence for a potential role for IL-15 in inflammation. Mice that are genetically deficient in IL-15 or its unique receptor subunit IL-15Ra have recently been generated. These mice provide us with valuable tools to address the importance of IL-15 in immune responses. This chapter focuses on studies with the IL-15 deficient mice to address specific roles for IL-15 in the generation and function of immune cells. Wherever applicable, comparisons are provided to studies in IL-15Ra deficient mice.
Analysis of IL-15 and IL-15Ra deficient mice has shown that IL-15 is a crucial factor for the maturation, survival, and activation of NK cells. Furthermore, IL-15 is important for the survival of NK-T cells, differentiation, and activation of IEL and dendritic epidermal T-cells (DETC). Although the generation of primary and memory CD8 T-cell responses were not compromised significantly in IL-15 deficient mice, IL-15 plays an important role in maintaining memory CD8 T-cell, but not memory CD4 T-cell, homeostasis. IL-15 is crucial for the long-term survival of memory CD8 T-cells and for the bystander proliferation of naïve CD8 T-cells. Furthermore, APC from both IL-15 and IL-I5Ra deficient mice are defective in both IFNy and NO production, suggesting that IL-15 is important for both innate (APC, NK) as well as adaptive immunity (CD8 T-cells). Characterization of the IL-15 deficient mice has also provided another surprising function of IL-15 in the survival of kidney epithelial cells. The chapter also provides a summary of in vivo inflammation experiments performed in IL-15 deficient mice to identify a potential role for IL-15 in inflammatory disease. Although IL-15 deficient mice have normal DTH and contact hypersensitivity responses, they are increasingly susceptible to colitis suggesting that IL-15 may play an anti-inflammatory role in gut responses. Based on these studies, IL-15 or its unique IL-15Ra chain could serve as targets for therapy in human disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burton, J. D., Bamford, R. N., Peters, C., et al. (1994) A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91, 4935–4939.
Grabstein, K. H., Eisenman, J., Shanebeck, K., et al. (1994) Cloning of a T cell growth factor that interacts with the 13 chain of the interleukin-2 receptor. Science 264, 965–968.
Bazan, J. F. (1990) Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350–354.
Bamford, R. N., Grant, A. J., Burton, J. D., et al. (1994) The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91, 4940–4944.
Carson, W. E., Giri, J. G., Lindemann, M. J., et al. (1994) Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180, 1395–1403.
Giri, J. G., Ahdieh, M., Eisenman, J., et al. (1994) Utilization of the 13 and y chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13, 2822–2830.
Giri, J. G., Kumaki, S., Ahdieh, M., et al. (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J. 14, 3654–3663.
Anderson, D. M., Kumaki, S., Ahdieh, M., et al. (1995) Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270, 29862–29869.
Fehniger, T. A. and Caligiuri, M. A. (2001) Interleukin 15: biology and relevance to human disease. Blood 97, 14–32.
Waldmann, T. A., Dubois, S., and Tagaya, Y. (2001) Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14, 105–110.
Kundig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., and Horak, I. (1993) Immune responses in interleukin-2-deficient mice. Science 262, 1059–1061.
Suzuki, H., Kundig, T. M., Furlonger, C., et al. (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472–1476.
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., and Alt, F. W. (1995) Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530.
Suzuki, H., Duncan, G. S., Takimoto, H., and Mak, T. W. (1997) Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor (3 chain. J. Exp. Med. 185, 499–505.
Ohteki, T., Ho, S., Suzuki, H., Mak, T. W., and Ohashi, P. S. (1997) Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development. J. Immunol. 159, 5931–5935.
Boesteanu, A., De Silva, A. D., Nakajima, H., Leonard, W. J., Peschon, J. J., and Joyce, S. (1997) Distinct roles for signals relayed through the common cytokine receptor y chain and interleukin 7 receptor a chain in natural T cell development. J. Exp. Med. 186, 331–336.
Di Santo, J. P., Colucci, F., and Guy-Grand, D. (1998) Natural killer and T cells of innate and adaptive immunity: lymphoid compartments with different requirements for common gamma chain-dependent cytokines. Immunol. Rev. 165, 29–38.
Mrozek, E., Anderson, P., and Caligiuri, M. A. (1996) Role of interleukin-l5 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood 87, 2632–2640.
Puzanov, I. J., Bennett, M., and Kumar, V. (1996) IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 157, 4282–4285.
Ohteki, T., Yoshida, H., Matsuyama, T., Duncan, G. S., Mak, T. W., and Ohashi, P. S. (1998) The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187, 967–972.
Inagaki-Ohara, K., Nishimura, H., Mitani, A., and Yoshikai, Y. (1997) Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice. Eur. J. Immunol. 27, 2885–2891.
Zhang, X., Sun, S., Hwang, I., Tough, D. F., and Sprent, J. (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8, 591–599.
Quinn, L. S., Haugk, K. L., and Grabstein, K. H. (1995) Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology 136, 3669–3672.
Ogata, Y., Kukita, A., Kukita, T., et al. (1999) A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2../. Immunol. 162, 2754–2760.
Tagaya, Y., Burton, J. D., Miyamoto, Y., and Waldmann, T. A. (1996) Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 15, 4928–4939.
Reinecker, H. C., MacDermott, R. P., Mirau, S., Dignass, A., and Podolsky, D. K. (1996) Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111, 1706–1713.
Bulfone-Pau, S. S., Bulanova, E., Pohl, T., et al. (1999) Death deflected: IL-15 inhibits TNFalpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J. 13, 1575–1585.
Kennedy, M. K., Glaccum, M., Brown, S. N., et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice [see comments]. J. Exp. Med. 191, 771–780.
Lodolce, J. P., Boone, D. L., Chai, S., et al. (1998) IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669–676.
Anderson, D. M., Johnson, L., Glaccum, M. B., et al. (1995) Chromosomal assignment and genomic structure of Il15. Genomics 25, 701–706.
Krause, H., Jandrig, B., Wernicke, C., Bulfone-Paus, S., Pohl, T., and Diamantstein, T. (1996) Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15). Cytokine 8, 667–674.
Williams, N. S., Moore, T. A., Schatzle, J. D., et al. (1997) Generation of lytic natural killer 1.1+, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186, 1609–1614.
Williams, N. S., Klem, J., Puzanov, I. J., Sivakumar, P. V., Bennett, M., and Kumar, V. (1999) Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells. J. Immunol. 163, 2648–2656.
Cooper, M. A., Bush, J. E., Fehniger, T. A., et al. (2002) In vivo evidence for a dependence on interleukin-15 for natural killer cell survival. Blood 10, 3633–3638.
Edelbaum, D., Mohamadzadeh, M., Bergstresser, P. R., Sugamura, K., and Takashima, A. (1995) Interleukin (IL)-15 promotes the growth of murine epidermal gamma delta T cells by a mechanism involving the beta-and gamma c-chains of the IL- 2 receptor. J. Invest. Dermatol. 105, 837–843.
Kawai, K., Suzuki, H., Tomiyama, K., Minagawa, M., Mak, T. W., and Ohashi, P. S. (1998) Requirement of the IL-2 receptor beta chain for the development of Vgamma3 dendritic epidermal T cells. J. Invest. Dermatol. 110, 961–965.
Ye, S. K., Maki, K., Lee, H. C., et al. (2001) Differential roles of cytokine receptors in the development of epidermal gamma delta T cells. J. Immunol. 167, 1929–1934.
De Creus, A., Van Beneden, K., Stevenaert, F., Debacker, V., Plum, J., and Leclercq, G. (2002) Developmental and functional defects of thymic and epidermal V gamma 3 cells in IL-15-deficient and IFN regulatory factor-l-deficient mice. J. Immunol. 168, 6486–6493.
Karupiah, G., Woodhams, C. E., Blanden, R. V., and Ramshaw, I. A. (1991) Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J. Immunol. 147, 4327–4332.
Buller, R. M. and Palumbo, G. J. (1991) Poxvirus pathogenesis. Microbiol. Rev. 55, 80–122.
Ruby, J. and Ramshaw, I. (1991) The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 10, 353–358.
Schluns, K. S., Williams, K., Ma, A., Zheng, X. X., and Lefrancois, L. (2002) Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168, 4827–4831.
Becker, T. C., Wherry, E. J., Boone, D., et al. (2002) Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195, 1541–1548.
Murali-Krishna, K., Lau, L. L., Sambhara, S., Lemonnier, F., Altman, J., and Ahmed, R. (1999) Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286, 1377–1381.
Swain, S. L., Hu, H., and Huston, G. (1999) Class II-independent generation of CD4 memory T cells from effectors. Science 286, 1381–1383.
Kassiotis, G., Garcia, S., Simpson, E., and Stockinger, B. (2002) Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat. Immunol. 3, 244–250.
Rocha, B. (2002) Requirements for memory maintenance. Nat. Immunol. 3, 209–210.
Yajima, T., Nishimura, H., Ishimitsu, R., et al. (2002) Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure. J. Immunol. 168, 1198–1203.
Fehniger, T. A., Suzuki, K., Ponnappan, A., et al. (2001) Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 193, 219–231.
Goldrath, A. W., Sivakumar, P. V., Glaccum, M., et al. (2002) Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J. Exp. Med. 195, 1515–1522.
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., and Carbone, F. R. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76, 17–27.
Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J., and Surh, C. D. (2002) Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195, 1523–1532.
Lodolce, J. P., Burkett, P. R., Boone, D. L., Chien, M., and Ma, A. (2001) T cell-independent interleukin 15Ralpha signals are required for bystander proliferation. J. Exp. Med. 194, 1187–1194.
Miller, R. E., Jones, J., Le, T., et al. (2002) 4–1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40dependent manner. J. Immunol. 169, 1792–1800.
Kim, Y. S., Maslinski, W., Zheng, X. X., et al. (1998) Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J. Immunol. 160, 5742–5748.
Kehren, J., Desvignes, C., Krasteva, M., et al. (1999) Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J. Exp. Med. 189, 779–786.
Kaminski, M. J., Bergstresser, P. R., and Takashima, A. (1993) In vivo activation of mouse dendritic epidermal T cells in sites of contact dermatitis. Eur. J. Immunol. 23, 1715–1718.
Shiohara, T. and Moriya, N. (1997) Epidermal T cells: their functional role and disease relevance for dermatologists. J. Invest. Dermatol. 109, 271–275.
Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M., and Tabira, T. (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677–1687.
Shi, F. D., Takeda, K., Akira, S., Sarvetnick, N., and Ljunggren, H. G. (2000) IL-18 directs auto-reactive T cells and promotes autodestruction in the central nervous system via induction of IFNgamma by NK cells. J. Immunol. 165, 3099–3104.
Singh, A. K., Wilson, M. T., Hong, S., et al. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801–1811.
Jahng, A. W., Maricic, I., Pedersen, B., et al. (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789–1799.
Fritz, R. B. and Zhao, M. L. (2001) Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J mouse by NK1.1+, DX5+, alpha beta+ T cells. J. Immunol. 166, 4209–4215.
Pal, E., Tabira, T., Kawano, T., Taniguchi, M., Miyake, S., and Yamamura, T. (2001) Costimulationdependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. J. Immunol. 166, 662–668.
Encinas, J. A., Lees, M. B., Sobel, R. A., et al. (2001) Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int. Immunol. 13, 257–264.
Fehniger, T. A., Yu, H., Cooper, M. A., Suzuki, K., Shah, M. H., and Caligiuri, M. A. (2000) Cutting edge: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFNgamma production in vivo. J. Immunol. 164, 1643–1647.
Seki, S., Habu, Y., Kawamura, T., et al. (2000) The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol. Rev. 174, 35–46.
Kim, S., lizuka, K., Aguila, H. L., Weissman, I. L., and Yokoyama, W. M. (2000) In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97, 2731–2736.
Lindemann, R. A. (1991) The regulatory effects of monocytes on human natural killer cells activated by lipopolysaccharides. J. Periodontal Res. 26, 486–490.
Mattei, F., Schiavoni, G., Belardelli, F., and Tough, D. F. (2001) IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167, 1179–1187.
Ohteki, T., Suzue, K., Maki, C., Ota, T., and Koyasu, S. (2001) Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2, 1138–1143.
Kirman, I. and Nielsen, O. H. (1996) Increased numbers of interleukin-l5-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91, 1789–1794.
Liu, Z., Geboes, K., Colpaert, S., D’Haens, G. R., Rutgeerts, P., and Ceuppens, J. L. (2000) IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 164, 3608–3615.
Lai, Y. G., Gelfanov, V., Gelfanova, V., et al. (1999) IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes. J. Immunol. 163, 5843–5850.
Porter, B. O. and Malek, T. R. (1999) IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development. J. Immunol. 163, 5906–5912.
Nielsen, O. H., Vainer, B., Bregenholt, S., Claesson, M. H., Bishop, P. D., and Kirman, I. (1997) Inflammatory bowel disease: potential therapeutic strategies. Cytokines Cell. Mol. Ther. 3, 267–281.
Cao, S., Black, J. D., Troutt, A. B., and Rustum, Y. M. (1998) Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cancer Res. 58, 3270–3274.
Shinozaki, M., Hirahashi, J., Lebedeva, T., et al. (2002) IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J. Clin. Invest. 109, 951–960.
Lugering, N., Kucharzik, T., Maaser, C., Kraft, M., and Domschke, W. (1999) Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells. Immunology 98, 504–509.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sivakumar, P.V., Brown, S.N., Goldrath, A.W., Van der Vuurst de Vries, A.R., Viney, J.L., Kennedy, M.K. (2003). IL-15. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-59259-405-4_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-415-9
Online ISBN: 978-1-59259-405-4
eBook Packages: Springer Book Archive